Clinical Trial Update: Visual Function With Contralateral AcrySof® ReSTOR® Aspheric SN6AD1 and SN6AD3 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating contralateral AcrySof ReSTOR SN6AD1 and SN6AD3 intraocular lenses for visual function in cataract patients; results are posted after st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• AcrySof ReSTOR SN6AD1
• AcrySof ReSTOR SN6AD3

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 4 | Status: TERMINATED | Results posted: 2011-11-08